Evaluating effective measles vaccine coverage in the Malaysian population accounting for between-dose correlation and vaccine efficacy [PDF]
BMC Public Health, 2023 Background Malaysia introduced the two dose measles-mumps-rubella (MMR) vaccine in 2004 as part of its measles elimination strategy. However, despite high historical coverage of MCV1 and MCV2, Malaysia continues to report high measles incidence.
Shurendar Selva Kumar +4 more
doaj +3 more sources
Measles vaccine uptake among Italian medical students compared to the pre-COVID-19 era [PDF]
Human Vaccines & Immunotherapeutics, 2023 The COVID-19 pandemic has severely affected health systems worldwide and raised the issue of vaccine hesitancy. In 2022, the World Health Organization reported an outbreak of measles infection among people over 20 years of age in the European Region ...
Cristiana Ferrari +10 more
doaj +2 more sources
Construction and Preclinical Evaluation of a Recombinant Attenuated Measles Vaccine Candidate of the H1a Genotype [PDF]
VaccinesBackground: Measles, an acute respiratory infectious disease caused by the measles virus, continues to pose a significant threat to children under five years old worldwide.
Lixia Xie +12 more
doaj +2 more sources
How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? – evidence from Nigeria [PDF]
Human Vaccines & ImmunotherapeuticsNigeria has the highest burden of measles worldwide, as measles vaccine uptake remains low. Recently, the second dose of the measles-containing vaccine (MCV2) was introduced as part of the routine immunization (RI) program, and this study examined how it
Ryoko Sato
doaj +2 more sources
Predictors for low coverage of uptake of second dose of measles vaccine among children in sub-Saharan Africa, 2023: a systematic review and meta-analysis [PDF]
Journal of Pharmaceutical Policy and PracticeBackground Measles became a public health important disease in sub-Saharan Africa. World Health Organization recommended measles-containing vaccine dose 2 (MCV2) through routine service delivery.
Tamirat Melis +5 more
doaj +2 more sources
Co-detection of the measles vaccine and wild-type virus by real-time PCR: public health laboratory protocol [PDF]
Access Microbiol, 2021 Kamelia R. Stanoeva +2 more
openalex +2 more sources
Molecular Therapy: Oncolytics, 2019 Measles virus (MeV) is naturally cytolytic by extensive cell-to-cell fusion. Vaccine-derived MeV is toxic for cancer cells and is clinically tested as oncolytic virus.
Jan R.H. Hanauer +3 more
doaj +1 more source
Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models [PDF]
, 2009 We evaluated the effectiveness of a measles vaccine campaign in rural Kenya, based on oral-fluid surveys and mixture-modelling analysis. Specimens were collected from 886 children aged 9 months to 14 years pre-campaign and from a comparison sample of 598
A. BETT +13 more
core +2 more sources
Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China. [PDF]
PLoS ONE, 2017 The safety of measles vaccination is of great interest and importance to public health practice and the general society. We have analyzed the adverse events following immunization (AEFIs) of currently used measles-containing vaccines (including live ...
Fan-Ya Meng +7 more
doaj +1 more source
A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions. [PDF]
, 2014 Observational studies and trials from low-income countries indicate that measles vaccine has beneficial nonspecific effects, protecting against non-measles-related mortality.
Aaby +54 more
core +2 more sources